News from EMA

“News from EMA” is published by ESMO Open based on information from the European Medicines Agency (EMA). Through this communication, ESMO Open aims to highlight new cancer drugs recently approved by EMA as a service to readers of the journal and the oncology community. The views expressed are those of the authors and do not necessarily reflect those of EMA, ESMO, the Editor or Publisher of the journal.

2018

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23rd-26th April 2018 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22nd March 2018 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2018 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22nd-25th January 2018 >>

2017

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14th December 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 May 2017 >>

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 April 2017 >>

Rituximab biosimilars open new horizons in immunotherapy >>